| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10787-018-0514-9 |
| P698 | PubMed publication ID | 30062629 |
| P50 | author | Andréa Name Colado Simão | Q88336514 |
| Neide Tomimura Costa | Q90656136 | ||
| Tatiana Mayumi Veiga Iriyoda | Q90656141 | ||
| Daniela Frizon Alfieri | Q90656143 | ||
| Isaias Dichi | Q90656148 | ||
| P2860 | cites work | Oxidation in rheumatoid arthritis. | Q21195671 |
| Oxidative Stress Relevance in the Pathogenesis of the Rheumatoid Arthritis: A Systematic Review | Q26747207 | ||
| Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox? | Q26765800 | ||
| Clinical Relevance of Biomarkers of Oxidative Stress | Q26785512 | ||
| Oxidative stress: a concept in redox biology and medicine | Q27022650 | ||
| Mechanism of action for leflunomide in rheumatoid arthritis | Q28140432 | ||
| Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. | Q34089998 | ||
| Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial | Q34530459 | ||
| Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab | Q34658023 | ||
| Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK. | Q35190872 | ||
| Active leflunomide metabolite inhibits interleukin 1beta, tumour necrosis factor alpha, nitric oxide, and metalloproteinase-3 production in activated human synovial tissue cultures | Q35552648 | ||
| Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation. | Q36234050 | ||
| Serum level of oxidative stress marker is dramatically low in patients with rheumatoid arthritis treated with tocilizumab | Q36420808 | ||
| Influence of Insulin Resistance and TNF-α on the Inflammatory Process, Oxidative Stress, and Disease Activity in Patients with Rheumatoid Arthritis | Q37000208 | ||
| Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor | Q38584496 | ||
| Molecular Mechanisms behind Free Radical Scavengers Function against Oxidative Stress | Q39429504 | ||
| Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis in inflammatory arthritis | Q39830600 | ||
| The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species | Q41978298 | ||
| Effective tumour necrosis factor-blocking therapy reduces reactive oxygen metabolite level in rheumatoid arthritis | Q42219877 | ||
| Short-term effect of anti-TNF-alpha therapy on nitric oxide production in patients with severe rheumatoid arthritis. | Q42456958 | ||
| Oxidative stress and enzymatic antioxidant status in rheumatoid arthritis: a case control study. | Q42753271 | ||
| Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis | Q43962259 | ||
| Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor-alpha monoclonal antibody in patients with rheumatoid arthritis | Q44300633 | ||
| Leflunomide reduces nitric oxide production in patients with active rheumatoid arthritis | Q46436943 | ||
| Reduction of oxidative stress marker levels by anti-TNF-alpha antibody, infliximab, in patients with rheumatoid arthritis | Q46712588 | ||
| Identification of clinical parameters associated with serum oxidative stress in patients with rheumatoid arthritis | Q46914146 | ||
| Methotrexate reduces the levels of pentosidine and 8-hydroxy-deoxy guanosine in patients with rheumatoid arthritis | Q46956043 | ||
| Hypoxia inducible factor-1 alpha expression in human normal and osteoarthritic chondrocytes | Q47946563 | ||
| Free radical-mediated pre-hemolytic injury in human red blood cells subjected to lead acetate as evaluated by chemiluminescence. | Q50707869 | ||
| Infliximab is equivalently suppressing oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis. | Q51364675 | ||
| Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity. | Q51401255 | ||
| Infliximab reduces myeloperoxidase concentration in chronic inflammatory joint diseases. | Q51831127 | ||
| The effect of infliximab on oxidative stress in chronic inflammatory joint disease. | Q51912873 | ||
| Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice | Q61756889 | ||
| Association between butyrylcholinesterase activity and phenotypes, paraoxonase192 rs662 gene polymorphism and their enzymatic activity with severity of rheumatoid arthritis: Correlation with systemic inflammatory markers and oxidative stress, prelimi | Q62071536 | ||
| An experimental model for hydrogen peroxide-induced tissue damage. Effects of a single inflammatory mediator on (peri)articular tissues | Q69506389 | ||
| Displacement of linker for activation of T cells from the plasma membrane due to redox balance alterations results in hyporesponsiveness of synovial fluid T lymphocytes in rheumatoid arthritis | Q73407127 | ||
| Increased DNA damage and oxidative stress in patients with rheumatoid arthritis | Q79464253 | ||
| Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis | Q80695386 | ||
| Methotrexate selectively modulates TH1/TH2 balance in active rheumatoid arthritis patients | Q81483131 | ||
| Oxidative status in rheumatoid arthritis | Q82975766 | ||
| Serum protein oxidation in patients with rheumatoid arthritis and effects of infliximab therapy | Q83823925 | ||
| P433 | issue | 5 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 1151-1164 | |
| P577 | publication date | 2018-07-30 | |
| P1433 | published in | Inflammopharmacology | Q15751310 |
| P1476 | title | Influence of disease-modifying antirheumatic drugs on oxidative and nitrosative stress in patients with rheumatoid arthritis | |
| P478 | volume | 26 |
Search more.